

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 8.54390396 |
| 2 | * regulation of sequestering of triglyceride (GO:0010889) | 7.81532023 |
| 3 | triglyceride catabolic process (GO:0019433) | 6.41208947 |
| 4 | * brown fat cell differentiation (GO:0050873) | 6.24004806 |
| 5 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 6.14905462 |
| 6 | valine metabolic process (GO:0006573) | 5.88953578 |
| 7 | acylglycerol catabolic process (GO:0046464) | 5.81451762 |
| 8 | neutral lipid catabolic process (GO:0046461) | 5.81451762 |
| 9 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 5.49978366 |
| 10 | fatty acid transmembrane transport (GO:1902001) | 5.48074678 |
| 11 | biotin metabolic process (GO:0006768) | 5.41136390 |
| 12 | regulation of tight junction assembly (GO:2000810) | 5.34364835 |
| 13 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.20550782 |
| 14 | * white fat cell differentiation (GO:0050872) | 5.12014836 |
| 15 | positive regulation of glomerulus development (GO:0090193) | 5.05249508 |
| 16 | regulation of receptor binding (GO:1900120) | 5.02879250 |
| 17 | * regulation of cholesterol storage (GO:0010885) | 5.00904950 |
| 18 | fatty acid beta-oxidation (GO:0006635) | 4.98421552 |
| 19 | carnitine shuttle (GO:0006853) | 4.88595146 |
| 20 | triglyceride biosynthetic process (GO:0019432) | 4.62627119 |
| 21 | lipid storage (GO:0019915) | 4.62177053 |
| 22 | lipid particle organization (GO:0034389) | 4.62149960 |
| 23 | positive regulation of lipid storage (GO:0010884) | 4.56937682 |
| 24 | regulation of gonadotropin secretion (GO:0032276) | 4.53719447 |
| 25 | acylglycerol biosynthetic process (GO:0046463) | 4.44315806 |
| 26 | neutral lipid biosynthetic process (GO:0046460) | 4.44315806 |
| 27 | branched-chain amino acid catabolic process (GO:0009083) | 4.28583576 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.28254238 |
| 29 | fatty acid catabolic process (GO:0009062) | 4.26105380 |
| 30 | * fatty acid oxidation (GO:0019395) | 4.25413474 |
| 31 | glycerolipid catabolic process (GO:0046503) | 4.24016291 |
| 32 | * positive regulation of fatty acid oxidation (GO:0046321) | 4.21000329 |
| 33 | branched-chain amino acid metabolic process (GO:0009081) | 4.19552855 |
| 34 | plasma lipoprotein particle clearance (GO:0034381) | 4.19037761 |
| 35 | * lipid oxidation (GO:0034440) | 4.17201767 |
| 36 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.15085455 |
| 37 | regulation of glomerulus development (GO:0090192) | 4.05081024 |
| 38 | * regulation of fatty acid oxidation (GO:0046320) | 4.03856964 |
| 39 | positive regulation of lipid catabolic process (GO:0050996) | 4.03218554 |
| 40 | * negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.02457976 |
| 41 | negative regulation of protein autophosphorylation (GO:0031953) | 4.01434592 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.00184246 |
| 43 | alpha-linolenic acid metabolic process (GO:0036109) | 3.99206972 |
| 44 | carnitine transmembrane transport (GO:1902603) | 3.93014267 |
| 45 | regulation of plasminogen activation (GO:0010755) | 3.92654768 |
| 46 | NADH metabolic process (GO:0006734) | 3.90302910 |
| 47 | diacylglycerol metabolic process (GO:0046339) | 3.86264671 |
| 48 | tricarboxylic acid cycle (GO:0006099) | 3.84377521 |
| 49 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.82591970 |
| 50 | peroxisome fission (GO:0016559) | 3.82213660 |
| 51 | acyl-CoA biosynthetic process (GO:0071616) | 3.79729270 |
| 52 | thioester biosynthetic process (GO:0035384) | 3.79729270 |
| 53 | wound healing, spreading of epidermal cells (GO:0035313) | 3.78542425 |
| 54 | triglyceride metabolic process (GO:0006641) | 3.74063332 |
| 55 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.74057651 |
| 56 | transcytosis (GO:0045056) | 3.68815800 |
| 57 | amino-acid betaine transport (GO:0015838) | 3.61897421 |
| 58 | carnitine transport (GO:0015879) | 3.61897421 |
| 59 | retinol metabolic process (GO:0042572) | 3.59553232 |
| 60 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.57387445 |
| 61 | * regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.54950645 |
| 62 | spindle assembly involved in mitosis (GO:0090307) | 3.53929792 |
| 63 | acylglycerol metabolic process (GO:0006639) | 3.52537842 |
| 64 | tricarboxylic acid metabolic process (GO:0072350) | 3.52336715 |
| 65 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.51536205 |
| 66 | mitochondrion morphogenesis (GO:0070584) | 3.51532127 |
| 67 | protein heterotrimerization (GO:0070208) | 3.48982135 |
| 68 | neutral lipid metabolic process (GO:0006638) | 3.46609395 |
| 69 | acetyl-CoA metabolic process (GO:0006084) | 3.45313966 |
| 70 | glycerol metabolic process (GO:0006071) | 3.42568381 |
| 71 | negative regulation of kidney development (GO:0090185) | 3.41570516 |
| 72 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.41251824 |
| 73 | * regulation of lipid storage (GO:0010883) | 3.40211207 |
| 74 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.39446122 |
| 75 | primary alcohol metabolic process (GO:0034308) | 3.39346016 |
| 76 | triglyceride homeostasis (GO:0070328) | 3.38646201 |
| 77 | acylglycerol homeostasis (GO:0055090) | 3.38646201 |
| 78 | coenzyme A biosynthetic process (GO:0015937) | 3.37611840 |
| 79 | NADPH regeneration (GO:0006740) | 3.37567467 |
| 80 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.37235921 |
| 81 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.35693058 |
| 82 | pentose-phosphate shunt (GO:0006098) | 3.35161639 |
| 83 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.33183526 |
| 84 | * positive regulation of fatty acid metabolic process (GO:0045923) | 3.32522390 |
| 85 | monocarboxylic acid catabolic process (GO:0072329) | 3.31016054 |
| 86 | positive regulation of cholesterol transport (GO:0032376) | 3.30219427 |
| 87 | positive regulation of sterol transport (GO:0032373) | 3.30219427 |
| 88 | intracellular lipid transport (GO:0032365) | 3.29901820 |
| 89 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.29299988 |
| 90 | flavonoid metabolic process (GO:0009812) | 3.27784052 |
| 91 | regulation of triglyceride metabolic process (GO:0090207) | 3.26276925 |
| 92 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.24741195 |
| 93 | * negative regulation of lipid storage (GO:0010888) | 3.24694774 |
| 94 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.24218265 |
| 95 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.23854865 |
| 96 | sulfur amino acid catabolic process (GO:0000098) | 3.20482781 |
| 97 | carnitine metabolic process (GO:0009437) | 3.19338972 |
| 98 | ethanol oxidation (GO:0006069) | 3.18612991 |
| 99 | negative regulation of macrophage differentiation (GO:0045650) | 3.18090395 |
| 100 | desmosome organization (GO:0002934) | 3.17588136 |
| 101 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.17191669 |
| 102 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.14752133 |
| 103 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.14484428 |
| 104 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.14130831 |
| 105 | apoptotic cell clearance (GO:0043277) | 3.13850553 |
| 106 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.13005496 |
| 107 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.11344575 |
| 108 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.11344575 |
| 109 | NADH dehydrogenase complex assembly (GO:0010257) | 3.11344575 |
| 110 | negative regulation of granulocyte differentiation (GO:0030853) | 3.11274693 |
| 111 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.10336571 |
| 112 | succinate metabolic process (GO:0006105) | 3.08531987 |
| 113 | positive regulation of cholesterol efflux (GO:0010875) | 3.07181325 |
| 114 | complement activation, alternative pathway (GO:0006957) | 3.07130239 |
| 115 | fatty acid homeostasis (GO:0055089) | 3.06747285 |
| 116 | regulation of lipid catabolic process (GO:0050994) | 3.03817537 |
| 117 | phagocytosis, recognition (GO:0006910) | 3.03734950 |
| 118 | positive regulation of glycolytic process (GO:0045821) | 3.02968593 |
| 119 | prostate gland growth (GO:0060736) | 3.00962577 |
| 120 | alditol metabolic process (GO:0019400) | 2.99405065 |
| 121 | somite development (GO:0061053) | 2.98946671 |
| 122 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.97369894 |
| 123 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.96593283 |
| 124 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.96593283 |
| 125 | homocysteine metabolic process (GO:0050667) | 2.96048978 |
| 126 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.94104433 |
| 127 | cellular lipid catabolic process (GO:0044242) | 2.93790190 |
| 128 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.93686930 |
| 129 | epoxygenase P450 pathway (GO:0019373) | 2.93346379 |
| 130 | growth hormone receptor signaling pathway (GO:0060396) | 2.92662823 |
| 131 | negative regulation of lipase activity (GO:0060192) | 2.89433974 |
| 132 | mitochondrial fusion (GO:0008053) | 2.88752765 |
| 133 | 2-oxoglutarate metabolic process (GO:0006103) | 2.88104594 |
| 134 | positive regulation of glucose import (GO:0046326) | 2.87467880 |
| 135 | negative regulation of cartilage development (GO:0061037) | 2.86543160 |
| 136 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.85550855 |
| 137 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.85506549 |
| 138 | phosphatidic acid biosynthetic process (GO:0006654) | 2.84573156 |
| 139 | phosphatidic acid metabolic process (GO:0046473) | 2.84573156 |
| 140 | phospholipid homeostasis (GO:0055091) | 2.83892635 |
| 141 | myelination in peripheral nervous system (GO:0022011) | 2.82663901 |
| 142 | peripheral nervous system axon ensheathment (GO:0032292) | 2.82663901 |
| 143 | regulation of coenzyme metabolic process (GO:0051196) | 2.80674135 |
| 144 | regulation of cofactor metabolic process (GO:0051193) | 2.80674135 |
| 145 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.78652459 |
| 146 | negative regulation of phagocytosis (GO:0050765) | 2.77811108 |
| 147 | daunorubicin metabolic process (GO:0044597) | 2.74581934 |
| 148 | polyketide metabolic process (GO:0030638) | 2.74581934 |
| 149 | doxorubicin metabolic process (GO:0044598) | 2.74581934 |
| 150 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.73789025 |
| 151 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.73457959 |
| 152 | * cellular response to lithium ion (GO:0071285) | 2.69456796 |
| 153 | regulation of energy homeostasis (GO:2000505) | 2.69443120 |
| 154 | negative regulation of heart growth (GO:0061117) | 2.69285024 |
| 155 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.69285024 |
| 156 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.69020756 |
| 157 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.67959124 |
| 158 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.67597758 |
| 159 | regulation of vitamin metabolic process (GO:0030656) | 2.67238605 |
| 160 | L-ascorbic acid metabolic process (GO:0019852) | 2.66885218 |
| 161 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.66303651 |
| 162 | response to nitrosative stress (GO:0051409) | 2.66173017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 6.03777373 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.63290646 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.20250476 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.05083542 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56089576 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.26367653 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.19369665 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.13874917 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.94144696 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.84631575 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.36987278 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.32464500 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.29700380 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21128004 |
| 15 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 11.8115703 |
| 16 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.96718468 |
| 17 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.96102070 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95847215 |
| 19 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89701426 |
| 20 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.81723098 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78413856 |
| 22 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.71729965 |
| 23 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.69640800 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.65882042 |
| 25 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.65013911 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64295444 |
| 27 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.63197231 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54747829 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52781312 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51302566 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51071691 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.50889915 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.50106116 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48430545 |
| 35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47718580 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47708164 |
| 37 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.44640178 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44298647 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.44137036 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.44137036 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43399321 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.38943280 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37565450 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35522846 |
| 45 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.33330701 |
| 46 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.32947851 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.30756258 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.27535062 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26222097 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25637586 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24125348 |
| 52 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23348274 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23251520 |
| 54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23251520 |
| 55 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22213839 |
| 56 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21825944 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21096663 |
| 58 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.20905167 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20848499 |
| 60 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.20199619 |
| 61 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19882516 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17469061 |
| 63 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15763184 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15573047 |
| 65 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14991154 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14572177 |
| 67 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14530707 |
| 68 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14530707 |
| 69 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.12415373 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12221024 |
| 71 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.12197270 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10589102 |
| 73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10172894 |
| 74 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.09604224 |
| 75 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09431266 |
| 76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.08462613 |
| 77 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08233659 |
| 78 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07862152 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06472250 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06384989 |
| 81 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06286050 |
| 82 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04678555 |
| 83 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.03118127 |
| 84 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02984723 |
| 85 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01753025 |
| 86 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99549796 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99385455 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99113999 |
| 89 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97652473 |
| 90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97364985 |
| 91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97136765 |
| 92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.96073086 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94095946 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93378953 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93108314 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92697179 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92639613 |
| 98 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92018787 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90191787 |
| 100 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89752698 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88538281 |
| 102 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88445070 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87848696 |
| 104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87356220 |
| 105 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87348810 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87142516 |
| 107 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86830301 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.86103985 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85377871 |
| 110 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.84767960 |
| 111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84577445 |
| 112 | P68_20966046_ChIP-Seq_HELA_Human | 0.84515664 |
| 113 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83846013 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83594489 |
| 115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83594489 |
| 116 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82970873 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82853767 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82373622 |
| 119 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.81448902 |
| 120 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81419327 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81145074 |
| 122 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81050510 |
| 123 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.81006929 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80612449 |
| 125 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80332800 |
| 126 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.80151624 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79956372 |
| 128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79693034 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79394632 |
| 130 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.78299469 |
| 131 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.77968119 |
| 132 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.77818114 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76579515 |
| 134 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.76329862 |
| 135 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.75975361 |
| 136 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73382704 |
| 137 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71386643 |
| 138 | SPI1_23127762_ChIP-Seq_K562_Human | 0.70239356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005670_abnormal_white_adipose | 5.47867636 |
| 2 | * MP0005666_abnormal_adipose_tissue | 4.65011062 |
| 3 | * MP0004130_abnormal_muscle_cell | 4.41181359 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.96150122 |
| 5 | * MP0004185_abnormal_adipocyte_glucose | 3.75407706 |
| 6 | * MP0005375_adipose_tissue_phenotype | 3.51816978 |
| 7 | MP0000516_abnormal_urinary_system | 3.37944126 |
| 8 | MP0005367_renal/urinary_system_phenotyp | 3.37944126 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.19297718 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.93190857 |
| 11 | * MP0002971_abnormal_brown_adipose | 2.89767344 |
| 12 | MP0005646_abnormal_pituitary_gland | 2.87653327 |
| 13 | MP0009053_abnormal_anal_canal | 2.80355506 |
| 14 | MP0003315_abnormal_perineum_morphology | 2.70726067 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.41031213 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.37717336 |
| 17 | MP0005275_abnormal_skin_tensile | 2.29659978 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.20096802 |
| 19 | * MP0009115_abnormal_fat_cell | 2.18152241 |
| 20 | * MP0005334_abnormal_fat_pad | 2.16353358 |
| 21 | * MP0000003_abnormal_adipose_tissue | 2.13371890 |
| 22 | MP0005365_abnormal_bile_salt | 2.13282010 |
| 23 | MP0001849_ear_inflammation | 2.10516273 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 2.08473824 |
| 25 | MP0004272_abnormal_basement_membrane | 2.00909533 |
| 26 | MP0000537_abnormal_urethra_morphology | 1.88088258 |
| 27 | MP0005360_urolithiasis | 1.83006016 |
| 28 | * MP0000013_abnormal_adipose_tissue | 1.81998337 |
| 29 | * MP0002970_abnormal_white_adipose | 1.79863231 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.78552381 |
| 31 | MP0000609_abnormal_liver_physiology | 1.74985950 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.73322020 |
| 33 | MP0005535_abnormal_body_temperature | 1.72566903 |
| 34 | MP0003011_delayed_dark_adaptation | 1.70556901 |
| 35 | MP0000343_altered_response_to | 1.63622617 |
| 36 | MP0001879_abnormal_lymphatic_vessel | 1.60412366 |
| 37 | MP0002876_abnormal_thyroid_physiology | 1.59611760 |
| 38 | MP0004782_abnormal_surfactant_physiolog | 1.59227798 |
| 39 | MP0005448_abnormal_energy_balance | 1.51289071 |
| 40 | MP0001485_abnormal_pinna_reflex | 1.48791240 |
| 41 | MP0000049_abnormal_middle_ear | 1.46735620 |
| 42 | MP0000467_abnormal_esophagus_morphology | 1.43597092 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.41964420 |
| 44 | MP0003186_abnormal_redox_activity | 1.41110390 |
| 45 | * MP0003724_increased_susceptibility_to | 1.38554548 |
| 46 | MP0001881_abnormal_mammary_gland | 1.37265237 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.36528593 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.36311555 |
| 49 | MP0003828_pulmonary_edema | 1.35382963 |
| 50 | MP0003690_abnormal_glial_cell | 1.33805514 |
| 51 | MP0003959_abnormal_lean_body | 1.33380739 |
| 52 | MP0005647_abnormal_sex_gland | 1.31813818 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.27918724 |
| 54 | MP0003646_muscle_fatigue | 1.25258612 |
| 55 | * MP0002078_abnormal_glucose_homeostasis | 1.23322035 |
| 56 | MP0000534_abnormal_ureter_morphology | 1.19116901 |
| 57 | MP0006054_spinal_hemorrhage | 1.18459218 |
| 58 | MP0001764_abnormal_homeostasis | 1.17232904 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.15320444 |
| 60 | MP0005085_abnormal_gallbladder_physiolo | 1.11065865 |
| 61 | MP0010368_abnormal_lymphatic_system | 1.10160009 |
| 62 | MP0002796_impaired_skin_barrier | 1.09778232 |
| 63 | MP0002160_abnormal_reproductive_system | 1.09511062 |
| 64 | MP0003879_abnormal_hair_cell | 1.06739370 |
| 65 | MP0003045_fibrosis | 1.05140767 |
| 66 | MP0002896_abnormal_bone_mineralization | 1.04924939 |
| 67 | MP0006138_congestive_heart_failure | 1.03084623 |
| 68 | MP0005385_cardiovascular_system_phenoty | 1.02736596 |
| 69 | MP0001544_abnormal_cardiovascular_syste | 1.02736596 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02519689 |
| 71 | MP0008872_abnormal_physiological_respon | 1.02423670 |
| 72 | MP0009840_abnormal_foam_cell | 1.01306196 |
| 73 | MP0005332_abnormal_amino_acid | 1.00892445 |
| 74 | * MP0005319_abnormal_enzyme/_coenzyme | 1.00838478 |
| 75 | MP0003283_abnormal_digestive_organ | 1.00654271 |
| 76 | MP0008004_abnormal_stomach_pH | 0.97224254 |
| 77 | * MP0005452_abnormal_adipose_tissue | 0.97128756 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.96954591 |
| 79 | MP0002108_abnormal_muscle_morphology | 0.96531810 |
| 80 | MP0008961_abnormal_basal_metabolism | 0.95684506 |
| 81 | MP0009643_abnormal_urine_homeostasis | 0.92966448 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.92863952 |
| 83 | MP0002166_altered_tumor_susceptibility | 0.92429649 |
| 84 | * MP0005164_abnormal_response_to | 0.92197851 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91772458 |
| 86 | MP0002282_abnormal_trachea_morphology | 0.91063109 |
| 87 | MP0001756_abnormal_urination | 0.90768166 |
| 88 | MP0009763_increased_sensitivity_to | 0.90753706 |
| 89 | MP0000249_abnormal_blood_vessel | 0.90296139 |
| 90 | MP0003868_abnormal_feces_composition | 0.89744208 |
| 91 | * MP0002060_abnormal_skin_morphology | 0.89630712 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.89382662 |
| 93 | MP0009780_abnormal_chondrocyte_physiolo | 0.88456064 |
| 94 | MP0000163_abnormal_cartilage_morphology | 0.86969674 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.86428466 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.86205268 |
| 97 | MP0003252_abnormal_bile_duct | 0.83648469 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.83026132 |
| 99 | MP0003937_abnormal_limbs/digits/tail_de | 0.82158980 |
| 100 | MP0005257_abnormal_intraocular_pressure | 0.81712970 |
| 101 | MP0002254_reproductive_system_inflammat | 0.81630573 |
| 102 | MP0003806_abnormal_nucleotide_metabolis | 0.81388607 |
| 103 | MP0003119_abnormal_digestive_system | 0.80579271 |
| 104 | * MP0001533_abnormal_skeleton_physiology | 0.80093954 |
| 105 | MP0000750_abnormal_muscle_regeneration | 0.80045289 |
| 106 | MP0003942_abnormal_urinary_system | 0.79239965 |
| 107 | MP0005620_abnormal_muscle_contractility | 0.77101212 |
| 108 | MP0005503_abnormal_tendon_morphology | 0.76686158 |
| 109 | MP0003693_abnormal_embryo_hatching | 0.76117915 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.75316459 |
| 111 | MP0004858_abnormal_nervous_system | 0.75009993 |
| 112 | MP0003448_altered_tumor_morphology | 0.73894106 |
| 113 | MP0010234_abnormal_vibrissa_follicle | 0.72663963 |
| 114 | MP0003279_aneurysm | 0.72286944 |
| 115 | MP0001666_abnormal_nutrient_absorption | 0.71902923 |
| 116 | MP0004233_abnormal_muscle_weight | 0.70807479 |
| 117 | * MP0000598_abnormal_liver_morphology | 0.70785932 |
| 118 | MP0004019_abnormal_vitamin_homeostasis | 0.70693691 |
| 119 | MP0002972_abnormal_cardiac_muscle | 0.69971397 |
| 120 | * MP0004087_abnormal_muscle_fiber | 0.69867727 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.69135220 |
| 122 | MP0001851_eye_inflammation | 0.68985044 |
| 123 | MP0002909_abnormal_adrenal_gland | 0.68959098 |
| 124 | MP0000858_altered_metastatic_potential | 0.68237132 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.67741143 |
| 126 | MP0002006_tumorigenesis | 0.67614346 |
| 127 | MP0002135_abnormal_kidney_morphology | 0.67198690 |
| 128 | MP0002168_other_aberrant_phenotype | 0.67180103 |
| 129 | MP0003436_decreased_susceptibility_to | 0.67094143 |
| 130 | * MP0000627_abnormal_mammary_gland | 0.65292817 |
| 131 | MP0000383_abnormal_hair_follicle | 0.65289775 |
| 132 | MP0005595_abnormal_vascular_smooth | 0.64540340 |
| 133 | MP0001727_abnormal_embryo_implantation | 0.63810463 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.63793169 |
| 135 | MP0002115_abnormal_skeleton_extremities | 0.63598932 |
| 136 | MP0002295_abnormal_pulmonary_circulatio | 0.63564903 |
| 137 | MP0005330_cardiomyopathy | 0.63254752 |
| 138 | MP0004043_abnormal_pH_regulation | 0.63103817 |
| 139 | MP0003303_peritoneal_inflammation | 0.62280157 |
| 140 | * MP0003953_abnormal_hormone_level | 0.61867739 |
| 141 | MP0001958_emphysema | 0.60068321 |
| 142 | * MP0001661_extended_life_span | 0.59572830 |
| 143 | MP0009250_abnormal_appendicular_skeleto | 0.58654308 |
| 144 | MP0003453_abnormal_keratinocyte_physiol | 0.58547748 |
| 145 | MP0001873_stomach_inflammation | 0.58167197 |
| 146 | MP0000477_abnormal_intestine_morphology | 0.57908403 |
| 147 | MP0001440_abnormal_grooming_behavior | 0.55808180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 7.56963407 |
| 2 | Short 1st metacarpal (HP:0010034) | 7.56963407 |
| 3 | Abnormality of the 1st metacarpal (HP:0010009) | 7.04631393 |
| 4 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 5.83439202 |
| 5 | Abnormality of alanine metabolism (HP:0010916) | 5.83439202 |
| 6 | Hyperalaninemia (HP:0003348) | 5.83439202 |
| 7 | Stenosis of the external auditory canal (HP:0000402) | 5.32662707 |
| 8 | Fused cervical vertebrae (HP:0002949) | 5.22237051 |
| 9 | Short phalanx of the thumb (HP:0009660) | 5.04081696 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.77206265 |
| 11 | Hyperglycinuria (HP:0003108) | 4.52352424 |
| 12 | Congenital sensorineural hearing impairment (HP:0008527) | 4.40577005 |
| 13 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.27255018 |
| 14 | * Acanthosis nigricans (HP:0000956) | 4.24199628 |
| 15 | * Oligomenorrhea (HP:0000876) | 4.13016643 |
| 16 | Nausea (HP:0002018) | 4.08124363 |
| 17 | * Hypertriglyceridemia (HP:0002155) | 3.98117395 |
| 18 | Myoglobinuria (HP:0002913) | 3.90975841 |
| 19 | Ectopic kidney (HP:0000086) | 3.82222416 |
| 20 | Abnormality of the renal collecting system (HP:0004742) | 3.79047875 |
| 21 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 3.74031460 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.72478673 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.72478673 |
| 24 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.68597622 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.67977261 |
| 26 | Xanthomatosis (HP:0000991) | 3.62511886 |
| 27 | Myocardial infarction (HP:0001658) | 3.60071320 |
| 28 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.58781410 |
| 29 | Dicarboxylic aciduria (HP:0003215) | 3.58781410 |
| 30 | Carpal bone hypoplasia (HP:0001498) | 3.56268044 |
| 31 | Duplicated collecting system (HP:0000081) | 3.52566221 |
| 32 | Short humerus (HP:0005792) | 3.49043366 |
| 33 | Rhabdomyolysis (HP:0003201) | 3.45161239 |
| 34 | Epidermoid cyst (HP:0200040) | 3.44648351 |
| 35 | Bone cyst (HP:0012062) | 3.41186873 |
| 36 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.41085616 |
| 37 | Complement deficiency (HP:0004431) | 3.39299621 |
| 38 | Hydroxyprolinuria (HP:0003080) | 3.36120868 |
| 39 | Abnormality of proline metabolism (HP:0010907) | 3.36120868 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32661113 |
| 41 | Increased connective tissue (HP:0009025) | 3.21139216 |
| 42 | Increased muscle lipid content (HP:0009058) | 3.20966391 |
| 43 | Abnormality of the nasal septum (HP:0000419) | 3.20429233 |
| 44 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.18737543 |
| 45 | Generalized aminoaciduria (HP:0002909) | 3.11004966 |
| 46 | Hyperammonemia (HP:0001987) | 3.10745553 |
| 47 | Ketoacidosis (HP:0001993) | 3.10227034 |
| 48 | Absent thumb (HP:0009777) | 3.09509930 |
| 49 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.09152224 |
| 50 | Ketosis (HP:0001946) | 3.04114437 |
| 51 | Vaginal fistula (HP:0004320) | 3.00303990 |
| 52 | Difficulty running (HP:0009046) | 2.97172299 |
| 53 | Rectal fistula (HP:0100590) | 2.91698450 |
| 54 | Rectovaginal fistula (HP:0000143) | 2.91698450 |
| 55 | Hemorrhage of the eye (HP:0011885) | 2.91263962 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 2.90107532 |
| 57 | Ankle contracture (HP:0006466) | 2.87028319 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.83180460 |
| 59 | Cerebral aneurysm (HP:0004944) | 2.82940898 |
| 60 | Synostosis of carpal bones (HP:0005048) | 2.80084172 |
| 61 | Pendular nystagmus (HP:0012043) | 2.76667368 |
| 62 | Abnormal cartilage morphology (HP:0002763) | 2.75392338 |
| 63 | Hypercholesterolemia (HP:0003124) | 2.75149203 |
| 64 | Skin nodule (HP:0200036) | 2.72087951 |
| 65 | Abnormality of the costochondral junction (HP:0000919) | 2.70348763 |
| 66 | Intestinal fistula (HP:0100819) | 2.67149175 |
| 67 | Abnormality of carpal bone ossification (HP:0006257) | 2.65152772 |
| 68 | Ureteral duplication (HP:0000073) | 2.60718092 |
| 69 | Abnormality of complement system (HP:0005339) | 2.59181861 |
| 70 | Long foot (HP:0001833) | 2.57495898 |
| 71 | Paralysis (HP:0003470) | 2.55282140 |
| 72 | Broad metatarsal (HP:0001783) | 2.51500481 |
| 73 | Increased variability in muscle fiber diameter (HP:0003557) | 2.50849090 |
| 74 | Premature rupture of membranes (HP:0001788) | 2.49300463 |
| 75 | Pigmentary retinal degeneration (HP:0001146) | 2.47387248 |
| 76 | Follicular hyperkeratosis (HP:0007502) | 2.46582512 |
| 77 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.45883648 |
| 78 | Pancreatitis (HP:0001733) | 2.45466164 |
| 79 | Cupped ribs (HP:0000887) | 2.35227137 |
| 80 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.34898409 |
| 81 | Abnormality of glycolipid metabolism (HP:0010969) | 2.34518120 |
| 82 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.34518120 |
| 83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.34518120 |
| 84 | Conjunctival hamartoma (HP:0100780) | 2.33989988 |
| 85 | Ileus (HP:0002595) | 2.33638255 |
| 86 | Hepatic necrosis (HP:0002605) | 2.32783967 |
| 87 | Hyperglycinemia (HP:0002154) | 2.31799704 |
| 88 | Spinal rigidity (HP:0003306) | 2.31611580 |
| 89 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.31182353 |
| 90 | Flat acetabular roof (HP:0003180) | 2.29926849 |
| 91 | Growth hormone excess (HP:0000845) | 2.29249611 |
| 92 | Aortic dissection (HP:0002647) | 2.26817415 |
| 93 | Type 1 muscle fiber predominance (HP:0003803) | 2.26378375 |
| 94 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.25497023 |
| 95 | Aortic aneurysm (HP:0004942) | 2.24882437 |
| 96 | Autoimmune thrombocytopenia (HP:0001973) | 2.23307955 |
| 97 | Multiple enchondromatosis (HP:0005701) | 2.21390106 |
| 98 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20971128 |
| 99 | Renal cortical cysts (HP:0000803) | 2.20694834 |
| 100 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.20650704 |
| 101 | Humeroradial synostosis (HP:0003041) | 2.20499118 |
| 102 | Synostosis involving the elbow (HP:0003938) | 2.20499118 |
| 103 | Tetraparesis (HP:0002273) | 2.18342802 |
| 104 | Absent radius (HP:0003974) | 2.18199540 |
| 105 | Conjugated hyperbilirubinemia (HP:0002908) | 2.16977586 |
| 106 | * Insulin-resistant diabetes mellitus (HP:0000831) | 2.16226989 |
| 107 | Horseshoe kidney (HP:0000085) | 2.14496199 |
| 108 | Chromsome breakage (HP:0040012) | 2.13672523 |
| 109 | Chorioretinal atrophy (HP:0000533) | 2.13540365 |
| 110 | Abnormality of DNA repair (HP:0003254) | 2.12185445 |
| 111 | Subcapsular cataract (HP:0000523) | 2.10844610 |
| 112 | Metabolic acidosis (HP:0001942) | 2.10468782 |
| 113 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.10451898 |
| 114 | * Insulin resistance (HP:0000855) | 2.09818715 |
| 115 | Muscle stiffness (HP:0003552) | 2.09134881 |
| 116 | Deep venous thrombosis (HP:0002625) | 2.07061800 |
| 117 | Carpal synostosis (HP:0009702) | 2.06605842 |
| 118 | Vertebral compression fractures (HP:0002953) | 2.04359233 |
| 119 | Aplasia involving forearm bones (HP:0009822) | 2.04172596 |
| 120 | Absent forearm bone (HP:0003953) | 2.04172596 |
| 121 | Facial diplegia (HP:0001349) | 2.03620156 |
| 122 | Protrusio acetabuli (HP:0003179) | 2.03205447 |
| 123 | Large hands (HP:0001176) | 2.02967019 |
| 124 | Short thumb (HP:0009778) | 2.02617305 |
| 125 | Palpitations (HP:0001962) | 2.02017258 |
| 126 | Proximal tubulopathy (HP:0000114) | 2.01654671 |
| 127 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.00500597 |
| 128 | Axonal loss (HP:0003447) | 1.99397829 |
| 129 | Lipoatrophy (HP:0100578) | 1.98536488 |
| 130 | Abnormality of serum amino acid levels (HP:0003112) | 1.96177757 |
| 131 | Osteomalacia (HP:0002749) | 1.95392768 |
| 132 | Multiple lipomas (HP:0001012) | 1.95076365 |
| 133 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.93730924 |
| 134 | Prominent supraorbital ridges (HP:0000336) | 1.92475648 |
| 135 | Absent toe (HP:0010760) | 1.91985721 |
| 136 | Abnormal tarsal ossification (HP:0008369) | 1.91483512 |
| 137 | Abnormal ossification of hand bones (HP:0005921) | 1.91417180 |
| 138 | Slender build (HP:0001533) | 1.90963840 |
| 139 | Neoplasm of the adrenal gland (HP:0100631) | 1.90711111 |
| 140 | Hyporeflexia of lower limbs (HP:0002600) | 1.89611967 |
| 141 | Hypoplastic ischia (HP:0003175) | 1.88189583 |
| 142 | Vomiting (HP:0002013) | 1.84257318 |
| 143 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.84225433 |
| 144 | Abnormal hand bone ossification (HP:0010660) | 1.84217146 |
| 145 | Reticulocytopenia (HP:0001896) | 1.83514348 |
| 146 | Increased cerebral lipofuscin (HP:0011813) | 1.83380088 |
| 147 | Anal stenosis (HP:0002025) | 1.83048325 |
| 148 | Increased serum pyruvate (HP:0003542) | 1.82510867 |
| 149 | Abnormality of the humerus (HP:0003063) | 1.82467992 |
| 150 | Rickets (HP:0002748) | 1.81749665 |
| 151 | Aneurysm (HP:0002617) | 1.81074022 |
| 152 | Neonatal death (HP:0003811) | 1.81045808 |
| 153 | Ovoid vertebral bodies (HP:0003300) | 1.80960890 |
| 154 | Lethargy (HP:0001254) | 1.80718692 |
| 155 | Cortical dysplasia (HP:0002539) | 1.79955377 |
| 156 | Nonimmune hydrops fetalis (HP:0001790) | 1.79771629 |
| 157 | Hypergonadotropic hypogonadism (HP:0000815) | 1.79281875 |
| 158 | Synostosis involving bones of the hand (HP:0004278) | 1.78968332 |
| 159 | Abnormality of the upper arm (HP:0001454) | 1.76138638 |
| 160 | Vertebral fusion (HP:0002948) | 1.75640000 |
| 161 | Esophageal varix (HP:0002040) | 1.75507774 |
| 162 | Choanal stenosis (HP:0000452) | 1.75267815 |
| 163 | Cervical subluxation (HP:0003308) | 1.75096701 |
| 164 | Systemic lupus erythematosus (HP:0002725) | 1.74881974 |
| 165 | Keratoconus (HP:0000563) | 1.73629637 |
| 166 | Increased corneal curvature (HP:0100692) | 1.73629637 |
| 167 | Abnormality of the ischium (HP:0003174) | 1.73613863 |
| 168 | Methylmalonic aciduria (HP:0012120) | 1.68775019 |
| 169 | Accelerated skeletal maturation (HP:0005616) | 1.68385682 |
| 170 | Dysostosis multiplex (HP:0000943) | 1.68225765 |
| 171 | Hematochezia (HP:0002573) | 1.68161085 |
| 172 | Renal tubular acidosis (HP:0001947) | 1.68090777 |
| 173 | Vacuolated lymphocytes (HP:0001922) | 1.67505950 |
| 174 | Short hallux (HP:0010109) | 1.66203930 |
| 175 | Cerebral edema (HP:0002181) | 1.66191399 |
| 176 | Polycythemia (HP:0001901) | 1.64192925 |
| 177 | Lymphangioma (HP:0100764) | 1.64173078 |
| 178 | Increased mean platelet volume (HP:0011877) | 1.63528077 |
| 179 | Ventricular tachycardia (HP:0004756) | 1.61995826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.72774952 |
| 2 | MST1R | 4.48525980 |
| 3 | CAMK1D | 4.45994773 |
| 4 | EPHA2 | 4.10022002 |
| 5 | BCKDK | 3.52866457 |
| 6 | SIK1 | 3.38282531 |
| 7 | ERN1 | 3.21355198 |
| 8 | CAMK1G | 3.02811833 |
| 9 | KDR | 3.00112392 |
| 10 | PIK3CA | 2.94509704 |
| 11 | GRK1 | 2.91431819 |
| 12 | ACVR1B | 2.49135290 |
| 13 | PDK3 | 2.38528427 |
| 14 | PDK4 | 2.38528427 |
| 15 | TIE1 | 2.06915642 |
| 16 | RIPK1 | 2.05352157 |
| 17 | PDK2 | 2.04005715 |
| 18 | CDK8 | 2.01491533 |
| 19 | MET | 1.89580454 |
| 20 | WNK4 | 1.85439683 |
| 21 | PKN2 | 1.85053297 |
| 22 | STK39 | 1.82603995 |
| 23 | FRK | 1.82384455 |
| 24 | TGFBR2 | 1.80500793 |
| 25 | KSR2 | 1.63445915 |
| 26 | PAK4 | 1.55579860 |
| 27 | LMTK2 | 1.54891302 |
| 28 | NME2 | 1.47465243 |
| 29 | PDGFRA | 1.40082517 |
| 30 | MAP3K2 | 1.39159067 |
| 31 | JAK1 | 1.34885346 |
| 32 | PRKAA2 | 1.31055908 |
| 33 | TTN | 1.28733052 |
| 34 | EPHB2 | 1.23459957 |
| 35 | INSRR | 1.19387061 |
| 36 | ADRBK2 | 1.15282778 |
| 37 | FGFR3 | 1.14545563 |
| 38 | LATS1 | 1.11517835 |
| 39 | DDR2 | 1.10736798 |
| 40 | RPS6KB2 | 1.08842748 |
| 41 | RET | 1.05018160 |
| 42 | AKT3 | 1.03757397 |
| 43 | CDK6 | 1.01415347 |
| 44 | NEK9 | 0.99969556 |
| 45 | JAK2 | 0.98994782 |
| 46 | ADRBK1 | 0.98260396 |
| 47 | FGFR4 | 0.92685232 |
| 48 | CAMK1 | 0.91515040 |
| 49 | JAK3 | 0.91465774 |
| 50 | DMPK | 0.90489779 |
| 51 | PTK6 | 0.89773656 |
| 52 | FLT3 | 0.87573611 |
| 53 | PRKG2 | 0.86550183 |
| 54 | MYLK | 0.86005676 |
| 55 | SGK3 | 0.85890085 |
| 56 | PDPK1 | 0.83783834 |
| 57 | CAMKK2 | 0.78819795 |
| 58 | PLK2 | 0.76293421 |
| 59 | PHKG2 | 0.75551608 |
| 60 | PHKG1 | 0.75551608 |
| 61 | FGFR2 | 0.73070931 |
| 62 | GRK5 | 0.72837524 |
| 63 | PDGFRB | 0.72468077 |
| 64 | MAP3K3 | 0.71281979 |
| 65 | TBK1 | 0.68979343 |
| 66 | ICK | 0.67777427 |
| 67 | EPHB1 | 0.67539066 |
| 68 | MAP2K2 | 0.67384789 |
| 69 | PDK1 | 0.66886376 |
| 70 | PRKAA1 | 0.66195572 |
| 71 | IGF1R | 0.66117447 |
| 72 | PRKCI | 0.66058386 |
| 73 | STK24 | 0.65395786 |
| 74 | FER | 0.64953770 |
| 75 | LATS2 | 0.64235549 |
| 76 | SGK494 | 0.63882747 |
| 77 | SGK223 | 0.63882747 |
| 78 | PRKD2 | 0.63268058 |
| 79 | GSK3A | 0.63189869 |
| 80 | ABL2 | 0.61253047 |
| 81 | PRKCH | 0.61006085 |
| 82 | FGR | 0.60970777 |
| 83 | MAP2K3 | 0.60117618 |
| 84 | * MAP2K1 | 0.59391026 |
| 85 | TRPM7 | 0.58816704 |
| 86 | IRAK3 | 0.58209067 |
| 87 | CSNK1A1 | 0.58033756 |
| 88 | TESK1 | 0.57006493 |
| 89 | PTK2B | 0.56703182 |
| 90 | PIM2 | 0.55779626 |
| 91 | LRRK2 | 0.55672310 |
| 92 | TAOK3 | 0.53255948 |
| 93 | SGK2 | 0.51795781 |
| 94 | MAPK11 | 0.51614539 |
| 95 | PRKCE | 0.51225754 |
| 96 | CSK | 0.50788492 |
| 97 | MAP3K1 | 0.50246500 |
| 98 | AURKA | 0.50236770 |
| 99 | MTOR | 0.48967317 |
| 100 | BMX | 0.48697576 |
| 101 | STK3 | 0.48069026 |
| 102 | BMPR2 | 0.47622594 |
| 103 | MAP3K6 | 0.47358102 |
| 104 | MAPKAPK3 | 0.47169626 |
| 105 | TYK2 | 0.46455824 |
| 106 | ARAF | 0.45078718 |
| 107 | DAPK3 | 0.44695348 |
| 108 | PRKD1 | 0.44600496 |
| 109 | PAK2 | 0.43622972 |
| 110 | PRKACG | 0.43284904 |
| 111 | ERBB4 | 0.42971835 |
| 112 | CAMK2D | 0.42724336 |
| 113 | NTRK1 | 0.42586013 |
| 114 | KIT | 0.42298486 |
| 115 | EPHA3 | 0.41931104 |
| 116 | NME1 | 0.41741399 |
| 117 | PRKCD | 0.41604296 |
| 118 | CAMK2G | 0.41232785 |
| 119 | INSR | 0.41226577 |
| 120 | NUAK1 | 0.40942137 |
| 121 | MAPK12 | 0.40733285 |
| 122 | STK10 | 0.40412587 |
| 123 | RPS6KB1 | 0.40128462 |
| 124 | MAPK4 | 0.39104043 |
| 125 | ILK | 0.38569687 |
| 126 | FGFR1 | 0.37455161 |
| 127 | IRAK1 | 0.36962299 |
| 128 | PRKD3 | 0.36840658 |
| 129 | CAMK2B | 0.36611443 |
| 130 | MOS | 0.34163496 |
| 131 | ABL1 | 0.33740362 |
| 132 | SRC | 0.33014357 |
| 133 | GRK7 | 0.32778127 |
| 134 | CSF1R | 0.31405064 |
| 135 | STK38 | 0.30469339 |
| 136 | TGFBR1 | 0.29048695 |
| 137 | DAPK2 | 0.28220944 |
| 138 | PIK3CG | 0.27348378 |
| 139 | RPS6KA6 | 0.27033878 |
| 140 | CDK4 | 0.26786002 |
| 141 | TEC | 0.26429138 |
| 142 | PTK2 | 0.26387067 |
| 143 | DYRK3 | 0.26219999 |
| 144 | STK38L | 0.25757425 |
| 145 | PAK1 | 0.25695301 |
| 146 | PLK4 | 0.25102152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.20596039 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.98612234 |
| 3 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 3.92977822 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.60110393 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.44578328 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.44083914 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.42972223 |
| 8 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.93441560 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.75565641 |
| 10 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.39889380 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.04427696 |
| 12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.03356267 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02278391 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.89728897 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 1.88050638 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84323018 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83453684 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.80803368 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.71496366 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.61251809 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.57265918 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.54359939 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53309549 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51704880 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49724944 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.47227081 |
| 27 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.38779604 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35566098 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35453113 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29033245 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28307373 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26140673 |
| 33 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 1.20829449 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16907845 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.15995660 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15472722 |
| 37 | Insulin resistance_Homo sapiens_hsa04931 | 1.13458619 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08507719 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08431435 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03891868 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00561916 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98799371 |
| 43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98727653 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97398914 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95916005 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94224240 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91278394 |
| 48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86948230 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85922030 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81391186 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78792327 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77892940 |
| 53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74509640 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74068282 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73249587 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72176456 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69719019 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69484282 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67370859 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.65770868 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65410371 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64595844 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 0.63894785 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63592282 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62121723 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61545757 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.60622154 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.58512282 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53342978 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53236233 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.51310122 |
| 72 | Focal adhesion_Homo sapiens_hsa04510 | 0.51105588 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50790554 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50478480 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48161983 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47739402 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46992166 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46562923 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46290823 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45223122 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43521251 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42656152 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40799866 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39498447 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38021768 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37672074 |
| 87 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36735272 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36010101 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.35936783 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35768063 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32142076 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32110654 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31681829 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31671346 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31182418 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30899889 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.30081222 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.28617018 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.28263529 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.26812590 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26633525 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26385677 |
| 103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24190640 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.23793199 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23589644 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23187877 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23139831 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23051397 |
| 109 | Bladder cancer_Homo sapiens_hsa05219 | 0.22373049 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.22345618 |
| 111 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.20846023 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.20410100 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20139098 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20081405 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19134907 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.18903979 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18894671 |
| 118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18232545 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18129999 |
| 120 | Morphine addiction_Homo sapiens_hsa05032 | 0.17143848 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.17130907 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.16680731 |
| 123 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 0.16266622 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16182144 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.16030774 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.15711877 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.15620431 |
| 128 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.14179953 |
| 129 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13636409 |
| 130 | Adherens junction_Homo sapiens_hsa04520 | 0.13575767 |
| 131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.13340703 |
| 132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11994149 |

